|1.||Coppe, Jean-Philippe: 2 articles (03/2004 - 11/2003)|
|2.||Desprez, Pierre-Yves: 2 articles (03/2004 - 11/2003)|
|3.||Bennington, James L: 2 articles (03/2004 - 11/2003)|
|4.||Itahana, Yoko: 2 articles (03/2004 - 11/2003)|
|5.||Sharma, Pankaj: 1 article (05/2015)|
|6.||Chinaranagari, Swathi: 1 article (05/2015)|
|7.||Chaudhary, Jaideep: 1 article (05/2015)|
|8.||Al Moustafa, A-E: 1 article (03/2010)|
|9.||Sami, S: 1 article (03/2010)|
|10.||Akil, N: 1 article (03/2010)|
|2.||Prostatic Neoplasms (Prostate Cancer)
03/15/2004 - "We also manipulated Id-1 and Id-2 expression in LNCaP and PC3 prostate cancer cell lines and determined the effects on invasion in vitro, matrix metalloproteinase secretion, and proliferation. "
03/15/2004 - "This study aimed to identify the potential role of Id-1 and Id-2 proteins as molecular makers for prostate cancer progression. "
03/15/2004 - "We propose that both Id-1 and Id-2 proteins control prostate cancer cell phenotypes and could serve as molecular markers of aggressive human prostate cancer."
03/15/2004 - "In vitro, constitutive expression of Id-1, and to a lesser extent Id-2, converted nonaggressive LNCaP prostate cancer cells into more proliferative and invasive cells and increased their secretion of matrix metalloproteinases. "
03/15/2004 - "Both Id-1 and Id-2 proteins were up-regulated during human prostate cancer progression in vivo and were overexpressed in highly aggressive prostate cancer cells. "
|3.||Pancreatic Neoplasms (Pancreatic Cancer)
03/01/2010 - "Furthermore, the expression of E6 oncoprotein of high-risk HPVs was found to correlate with overexpression of Id-1, but not of Id-2, Id-3 or Id-4 in the majority of invasive cervical cancer tissue samples. "
08/01/2001 - "Using immunohistochemistry, we investigated the prognostic influence of Id-1, Id-2, and Id-3 expression in 89 patients with cervical cancer stage pT(1b). "
09/01/1999 - "In contrast, in dysplastic and atypical papillary ducts in CP, Id-1 and Id-2 immunoreactivity was as significantly elevated as in the cancer cells. "
09/01/1999 - "Scoring on the basis of percentage of positive cells and intensity of immunostaining indicated that Id-1 and Id-2 were increased significantly in the cancer cells by comparison with the respective controls. "
09/01/1999 - "In the cancer tissues, many of the cancer cells exhibited abundant Id-1, Id-2, and Id-3 immunoreactivity. "
|5.||Breast Neoplasms (Breast Cancer)
02/01/2010 - "Although the differentially expressed Id-2 and -3 may be correlated with some clinical parameters, they could not be used as independent prognostic factors in human breast cancer."
11/01/2003 - "In conclusion, Id-2 expression not only follows a pattern opposite to that of Id-1 during mammary gland development and breast cancer progression but also appears to act as an important protein for the maintenance of a differentiated and noninvasive phenotype in normal and transformed breast cells."
11/01/2003 - "We also show that Id-2 expression is inversely correlated with the rate of proliferation in murine mammary epithelial cells and that Id-2 is expressed at a higher level in differentiated human breast cancer cells in comparison with very aggressive and metastatic cells. "
11/01/2003 - "Role of Id-2 in the maintenance of a differentiated and noninvasive phenotype in breast cancer cells."
06/01/2009 - "The coding sequence of Id-2 gene was amplified by RT-PCR from the total RNA of breast cancer tissue. "
|1.||Proteins (Proteins, Gene)
|2.||Messenger RNA (mRNA)
|3.||Syndecan-1 (Syndecan 1)
|5.||Matrix Metalloproteinase 9 (Gelatinase B)
|6.||Transcription Factors (Transcription Factor)
|7.||RNA (Ribonucleic Acid)
|9.||Actins (F Actin)
|10.||death-associated protein kinase